Showing results (1351-1360 of 1,431) with videos related to
Sort By:
Pageof 144
Epidemiology and Infection|May 15, 2012
Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in KoreaS W Jung, H J Chae, Y J Park, et al.ACS Infectious Diseases|November 8, 2018
ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B InfectionEmily P Thi, Ammen P Dhillon, Andrzej Ardzinski, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2011
The impact of combined pulmonary fibrosis and emphysema on mortalityC-H Lee, H J Kim, C M Park, et al.Hepatology Communications|October 4, 2022
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis BMan-Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, et al.Science (New York, N.Y.)|September 18, 2012
Octet-line node structure of superconducting order parameter in KFe2As2K Okazaki, Y Ota, Y Kotani, et al.Nature Genetics|October 1, 2021
Increased somatic mutation burdens in normal human cells due to defective DNA polymerasesPhilip S Robinson, Tim H H Coorens, Claire Palles, et al.Gut|June 23, 2016
RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutationHelen H N Yan, Jeffrey C W Lai, Siu Lun Ho, et al.ESMO Open|December 6, 2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trialT K Choueiri, T M Kuzel, S S Tykodi, et al.Lupus|June 23, 2011
A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern TaiwanC T Weng, T J Chung, M F Liu, et al.Singapore Medical Journal|July 15, 2014
Ministry of Health Clinical Practice Guidelines: Diabetes MellitusS Y Goh, S B Ang, Y M Bee, et al.Pageof 144